Accueil・Liste d'Actions・Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc

Ouvert

4.41 -1.12

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.27

Max

4.8100000000000005

Chiffres clés
By Trading Economics
Revenu	-136K -35M
BPA	-0.503
Employés	106
EBITDA	2.2M -35M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+33.13% upside

Dividendes
By Acuity
Prochains Résultats	4 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	62M 357M
Ouverture précédente	5.53
Clôture précédente	4.41

Zentalis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 juil. 2026, 23:56 UTC

AAR Corp shares are higher in after-market hours, reflecting earlier fluctuations. The stock remains below its 20-day moving average and near its one-month trading range.

22 juil. 2026, 23:56 UTC

Correlated Moves

News

American Water Works Company Inc. is trading lower in after-market hours amid geopolitical tensions and rising crude oil prices impacting market sentiment.

22 juil. 2026, 23:56 UTC

HCA Healthcare Inc shares are trading higher in after-market hours. Broader market sentiment is influenced by geopolitical tensions and rising crude oil prices.

22 juil. 2026, 23:56 UTC

Correlated Moves

Lyft Inc shares are higher in after-market trading, showing a slight increase since Wednesday's close amid broader market dynamics and fluctuations in the ride-sharing sector.

22 juil. 2026, 23:56 UTC

Correlated Moves

Costco Wholesale shares are lower in after-market hours amid ongoing geopolitical tensions and rising crude oil prices affecting market sentiment.

22 juil. 2026, 23:56 UTC

ETF Constituents

The iShares Biotechnology ETF is trading higher in after-market hours, supported by gains from Medpace Holdings and other key holdings.

22 juil. 2026, 23:56 UTC

Correlated Moves

Element Solutions Inc shares are higher in after-market trading, reflecting a modest gain. Similar trends were noted in correlated asset ITT Inc.

22 juil. 2026, 23:56 UTC

Correlated Moves

Coeur Mining Inc shares are lower in after-market hours, reflecting a decline linked to a slight drop in silver prices.

22 juil. 2026, 23:56 UTC

Badger Meter Inc shares are higher in after-market trading, recovering from earlier volatility without any specific news to explain the movement.

22 juil. 2026, 23:56 UTC

Correlated Moves

Rambus Inc shares are higher in after-market trading, reflecting positive movement since Wednesday's close, alongside gains in MACOM Technology Solutions. Geopolitical tensions persist.

22 juil. 2026, 23:56 UTC

Exelon shares are lower in after-market trading, reflecting stable performance within a one-month trading range. No specific news was identified.

22 juil. 2026, 23:56 UTC

American Superconductor shares are lower in after-market trading, retracing from earlier gains and remaining below their 20-day moving average.

22 juil. 2026, 23:56 UTC

NextDecade Corp. shares are lower in after-market hours amid geopolitical tensions and rising oil prices, reflecting routine fluctuations without specific company news.

22 juil. 2026, 23:56 UTC

Comfort Systems USA Inc shares are lower in after-market trading, following a trend of higher closes. No specific news was identified for this movement.

22 juil. 2026, 23:56 UTC

MasTec Inc. shares are modestly higher in after-market hours, with no specific company news identified. Broader market sentiment may be influenced by geopolitical tensions.

22 juil. 2026, 23:56 UTC

Correlated Moves

Fortuna Silver Mines Inc. is trading lower in after-market hours, reflecting broader declines in the precious metals market amid ongoing geopolitical tensions.

22 juil. 2026, 23:56 UTC

News

Wynn Resorts received approval to expand its Wynn Palace resort in Macau, including a new hotel and entertainment center. Shares showed little change in after-market trading.

22 juil. 2026, 23:56 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, though they remain below their 20-day moving average and near the lower end of their one-month range.

22 juil. 2026, 23:56 UTC

ETF Constituents

iShares China Large-Cap ETF declines after market close, impacted by JD's negative return. The ETF remains above its 20-day moving average.

22 juil. 2026, 23:56 UTC

Newmont Corporation shares are higher in after-market hours, reflecting a modest increase since Wednesday's close, with no specific news identified for the movement.

22 juil. 2026, 23:56 UTC

Under Armour Inc shares are slightly higher in after-market hours, maintaining a position near the upper end of their one-month range.

22 juil. 2026, 23:52 UTC

Lumentum Holdings Inc shares are higher in after-market trading, significantly above Wednesday's close and near the upper end of its one-month trading range.

22 juil. 2026, 23:51 UTC

Blue Owl Capital Corp shares are higher in after-market trading. No specific news was identified to explain this movement amid cautious broader market sentiment.

22 juil. 2026, 23:51 UTC

Upwork Inc. shares are lower during after-market hours amid broader market declines. Rising crude oil prices and geopolitical tensions are contributing to negative sentiment.

22 juil. 2026, 23:51 UTC

MACOM Technology Solutions is higher in after-market trading, reflecting positive sentiment despite broader market concerns over rising crude oil prices and geopolitical tensions.

22 juil. 2026, 23:51 UTC

Pinnacle West Capital Corp shares are lower in after-market trading, continuing weak sentiment from earlier. Broader market dynamics may be influencing cautious investor sentiment.

22 juil. 2026, 23:51 UTC

HP Inc. shares are little changed in after-market trading. The broader market is lower amid rising crude oil prices and uncertainty over the Fed's interest rate decision.

22 juil. 2026, 23:51 UTC

Ambarella Inc shares are higher in after-market trading, recovering from earlier fluctuations. Broader market sentiment remains cautious amid rising crude oil prices.

22 juil. 2026, 23:51 UTC

Correlated Moves

Photronics Inc shares are higher in after-market trading, supported by a positive trend and correlations with MACOM Technology Solutions Holdings Inc.

22 juil. 2026, 23:51 UTC

PDD Holdings Inc shares are higher in after-market trading, despite no specific news driving the price movement. The stock remains above its 20-day moving average.

Comparaison

Variation de prix

Zentalis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

33.13% hausse

Prévisions sur 12 Mois

Moyen 6.67 USD 33.13%

Haut 10 USD

Bas 4 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

Achat

Maintien

Vente

Basé sur 7 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.